Revitope Oncology Obtains $8,500,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=02680f65-59cc-4513-8856-555555f06316
Date
2/9/2016
Company Name
Revitope Oncology
Mailing Address
Undisclosed San Francisco, CA 94105 USA
Company Description
Revitope Oncology, Inc. is a privately-held cancer immunotherapy company developing a novel platform based on redirecting viral immunity for the purpose of developing compounds to treat solid tumors and hematologic malignancies.
Website
http://www.revitope.com
Transaction Type
Venture Equity
Transaction Amount
$8,500,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds will be used to continue development of its novel immunotherapy platform for the treatment of solid tumors and hematologic malignancies.
M&A Terms
Venture Investor
Undisclosed